The Portuguese Pharmaceutical Society welcomes the objective of this draft Implementing Regulation to ensure that dataset catalogues for the secondary use of electronic health data are standardised and interoperable. High-quality metadata can support research in the public interest, public health, pharmacovigilance, and evidence generation on the use of medicines.
PPS
Portuguese Pharmaceutical Society
Public authority · Portugal · EU Transparency Register 8931887100000-78
3
positions filed
in the 665 files tracked
3
legislative files
of 665 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 71 associations and networks of public authorities on this site, they rank #34 by legislative files engaged, a count of participation, not a measure of influence.
0.2
declared lobbying FTE
self-declared
€10K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2025
in the register since
Declares membership of
- PGEU - Pharmaceutical Group of the European union: http://www.pgeu.eu/en/
- FIP - International Pharmaceutical Federation : www.fip.org
- AFPLP -Pharmacists Association of the Portuguese Speaking Countries : http://www.afplp.org/
- EUPLMG - European Union of Pharmacist Specialists in Laboratory Medicine and/or Human Genetics - https://euplmg.eu/a-…
- EIPG - European Industrial Pharmacists Group - https://mail.eipg.eu/
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Associations and networks of public authorities
- Registered as
- Ordem dos Farmacêuticos/ Portuguese Pharmaceutical Society (OF)
- Head office
- Lisboa, Portugal
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Portuguese in PolicySpeak: request access →
Work at Portuguese Pharmaceutical Society? so we know who speaks for it.
Their record over time
Portuguese Pharmaceutical Society filed 3 positions on 7 May 2026, across 3 of the 665 legislative files tracked here.
What they argued
The Portuguese Pharmaceutical Society supports MyHealth@EU as the common infrastructure for the cross-border primary use of electronic health data. For pharmacists, it will deliver value only if it makes cross-border electronic prescriptions safer, faster, and legally clear, while preserving confidentiality and continuity of supply.
he Portuguese Pharmaceutical Society welcomes the objective of the draft Implementing Regulation to ensure reliable cross-border identification and authentication for personal electronic health data. For pharmacists, these rules are particularly relevant at the point of care: they must identify the patient, verify their professional authorisation, and access only the data necessary for safe dispensing and patient…
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Portuguese Pharmaceutical Society next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 18.
Is this your organization?
Everything on this page comes from Portuguese Pharmaceutical Society’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.